Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

Mayuko Miyamoto

[ISP-022] Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

Mayuko Miyamoto, Kenjiro Sawada, Masaki Kobayashi, Aasa Shimizu, Misa Yamamoto, Taro Yagi, Tadashi Kimura (Obstetrics and gynecology, Osaka University, Osaka, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Presentation information

ISポスター発表5 IS5

[ISP-022] Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

Password